Nov 18, 2025 | Drug Policy Law, Hemp & Cannabis, Hemp and Cannabis
Last week, Congress passed a major federal funding bill designed to reopen the government; but tucked inside the legislation is a sweeping change to federal hemp policy that could upend a multibillion-dollar industry and reshape how products derived from the hemp...
Jul 30, 2025 | Uncategorized
The U.S. Food and Drug Administration is moving to restrict 7-hydroxymitragynine (7-OH), a derivative of the kratom plant that is commonly sold online and in vape stores. Citing concerns that 7-OH has opioid-like effects and could be similarly addictive, Health...
